Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age
Public ClinicalTrials.gov record NCT03211247. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Placebo-controlled, Randomized Phase III Trial to Assess the Safety and Efficacy of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study aims to assess the safety and efficacy of Viaskin Peanut to induce desensitization to peanut in peanut-allergic children 1 to 3 years of age after a 12-month treatment by EPicutaneous ImmunoTherapy (EPIT).
Study identification
- NCT ID
- NCT03211247
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 414 participants
Conditions and interventions
Conditions
Interventions
- Part A Viaskin Peanut 250 mcg Biological
- Part A Viaskin Peanut 100 mcg Biological
- Part A Placebo Biological
- Part B Viaskin Peanut 250 mcg Biological
- Part B Placebo Biological
Biological
Eligibility (public fields only)
- Age range
- 1 Year to 3 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2017 (Actual)
- Primary completion
- Aug 20, 2019 (Actual)
- Completion
- Apr 27, 2022 (Actual)
- Last update posted
- Dec 16, 2024
2017 – 2022
United States locations
- U.S. sites
- 27
- U.S. states
- 18
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona Health Science | Tucson | Arizona | 85719 | — |
| Arkansas Children's Hospital | Little Rock | Arkansas | 72202 | — |
| University of California School of Medicine | Los Angeles | California | 10833 | — |
| University of California, Rady Children's Hospital | San Diego | California | 92123 | — |
| University of California San Francisco | San Francisco | California | 94158 | — |
| Stanford University School of Medicine | Stanford | California | 94305 | — |
| Children's Hospital Colorado | Aurora | Colorado | 80045 | — |
| Children's national Health System | Washington D.C. | District of Columbia | 20010 | — |
| Emory University | Atlanta | Georgia | 30329 | — |
| Ann & Robert H. Lurie Children's Hospital of CHicago | Chicago | Illinois | 60611 | — |
| The Universal of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| Riley Hospital for Children at Indiana University | Indianapolis | Indiana | 46202 | — |
| Johns Hopkins Hospital | Baltimore | Maryland | 21205 | — |
| Boston Childrens' Hospital | Boston | Massachusetts | 02115 | — |
| University of Michigan Health System | Ann Arbor | Michigan | 48106 | — |
| Mount Sinai Medical Center | New York | New York | 10029 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| The University of North Carolina - Chapell Hill | Chapel Hill | North Carolina | 27599 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| Children's Hospital of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | — |
| Le Bonheur Children's Hospital | Memphis | Tennessee | 38105 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| Dell Children's Medical Center | Austin | Texas | 78723 | — |
| Children's Medical Center of Dallas | Dallas | Texas | 75235 | — |
| Baylor College of Medicine - Texas Children's Hospital | Houston | Texas | 77030 | — |
| ASTHMA, Inc. | Seattle | Washington | 98115 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03211247, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 16, 2024 · Synced Nov 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03211247 live on ClinicalTrials.gov.